Perfect! Now I have enough data. Let me create the article focusing on interesting short interest movements and avoiding the excluded tickers:
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Perfect! Now I have enough data. Let me create the article focusing on interesting short interest movements and avoiding the excluded tickers:
Bears Swarm Micro-Cap Biotechs
DRMA Dermata Therapeutics SI exploded 78 points this week to 83%. The $3.7M biotech saw bears pile in within three days jumping from 5% to 83% short interest. Cost to borrow hit 227% showing extreme positioning.
ORGN Origin Materials absorbed massive short surge climbing 89 points in three days. The sustainable materials play hit 93% SI up from 4% on March 20. The $276M company dropped 65 points over the week as bears unwound positions.
TNGX Tango Therapeutics held 70% SI unchanged. The $2.8B biotech soared 122% in three months yet maintained extreme short bets. Bears showed conviction despite the rally.
VELO Velo3D topped extremes at 81% SI. The 3D printing name held steady at elevated levels. SNSE Sensei Biotherapeutics climbed to 97% SI adding two points weekly showing persistent bearish pressure.
AIRS AirSculpt Technologies dropped to 165% from 208% last week. The cosmetic surgery play saw bears reduce bets by 43 points. Availability stayed above 100% showing ample shares to borrow.
Rental giants faced pressure. CAR Avis Budget hit 61% SI adding four points this week. HTZ Hertz climbed to 51% as transportation stocks drew skepticism.
Small-cap volatility dominated with micro biotechs seeing the wildest swings.
How this article was generated
- Generated
- 25 Mar 2026, 00:03
- Prompt version
- migrated
- Data sources
- Short interestCost to borrowUtilizationAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.